Back to Country Profile
Historical Values
Year Value
2008 degree of risk: intermediate food or waterborne diseases: bacterial diarrhea, hepatitis A water contact disease: leptospirosis (2008)
2009 degree of risk: intermediate food or waterborne diseases: bacterial diarrhea, hepatitis A water contact disease: leptospirosis (2009)
2010 degree of risk: intermediate food or waterborne diseases: bacterial diarrhea, hepatitis A water contact disease: leptospirosis (2009)
2011 degree of risk: intermediate food or waterborne diseases: bacterial diarrhea, hepatitis A water contact disease: leptospirosis (2009)
2012 degree of risk: intermediate food or waterborne diseases: bacterial diarrhea, hepatitis A water contact disease: leptospirosis (2009)
2016 note: active local transmission of Zika virus by Aedes species mosquitoes has been identified in this country (as of August 2016); it poses an important risk (a large number of cases possible) among US citizens if bitten by an infective mosquito; other less common ways to get Zika are through sex, via blood transfusion, or during pregnancy, in which the pregnant woman passes Zika virus to her fetus (2016)
2017 note: active local transmission of Zika virus by Aedes species mosquitoes has been identified in this country (as of August 2016); it poses an important risk (a large number of cases possible) among US citizens if bitten by an infective mosquito; other less common ways to get Zika are through sex, via blood transfusion, or during pregnancy, in which the pregnant woman passes Zika virus to her fetus (2016)
2018 note: active local transmission of Zika virus by Aedes species mosquitoes has been identified in this country (as of August 2016); it poses an important risk (a large number of cases possible) among US citizens if bitten by an infective mosquito; other less common ways to get Zika are through sex, via blood transfusion, or during pregnancy, in which the pregnant woman passes Zika virus to her fetus
2019 note: active local transmission of Zika virus by Aedes species mosquitoes has been identified in this country (as of August 2016); it poses an important risk (a large number of cases possible) among US citizens if bitten by an infective mosquito; other less common ways to get Zika are through sex, via blood transfusion, or during pregnancy, in which the pregnant woman passes Zika virus to her fetus
2020 note: widespread ongoing transmission of a respiratory illness caused by the novel coronavirus (COVID-19) is occurring throughout Argentina; as of 8 December 2020, Argentina has reported a total of 1,454,631 cases of COVID-19 or 32,185 cumulative cases of COVID-19 per 1 million population with 874 cumulative deaths per 1 million population
2021 note: widespread ongoing transmission of a respiratory illness caused by the novel coronavirus (COVID-19) is occurring throughout Argentina; as of 6 October 2021, Argentina has reported a total of 5,260,719 cases of COVID-19 or 11,639.85 cumulative cases of COVID-19 per 100,000 population with 255.07 cumulative deaths per 100,000 population; as of 5 October 2021, 50.49% of the population has received at least one dose of COVID-19 vaccine
2021 note: widespread ongoing transmission of a respiratory illness caused by the novel coronavirus (COVID-19) is occurring throughout Argentina; as of 6 October 2021, Argentina has reported a total of 5,260,719 cases of COVID-19 or 11,639.85 cumulative cases of COVID-19 per 100,000 population with 255.07 cumulative deaths per 100,000 population; as of 5 October 2021, 50.49% of the population has received at least one dose of COVID-19 vaccine
2022 note: widespread ongoing transmission of a respiratory illness caused by the novel coronavirus (COVID-19) is occurring throughout Argentina; as of 9 December 2022, Argentina has reported a total of 9,739,856 cases of COVID-19 or 21,550.36 cumulative cases of COVID-19 per 100,000 population with a total of 130,034 cumulative deaths or 287.7 cumulative deaths per 100,000 population; as of 8 December 2022, 91% of the population has received at least one dose of COVID-19 vaccine
2022 note: widespread ongoing transmission of a respiratory illness caused by the novel coronavirus (COVID-19) is occurring throughout Argentina; as of 9 December 2022, Argentina has reported a total of 9,739,856 cases of COVID-19 or 21,550.36 cumulative cases of COVID-19 per 100,000 population with a total of 130,034 cumulative deaths or 287.7 cumulative deaths per 100,000 population; as of 8 December 2022, 91% of the population has received at least one dose of COVID-19 vaccine